Back
Cognition Therapeutics, Inc. 10K Form
Sell
48
CGTX
Cognition Therapeutics, Inc.
Last Price:
$1.54
Seasonality Move:
24.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGTX News And Ratings
See the #1 stock for the next 7 days that we like better than CGTX
CGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-5.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.41 |
| Price / Book: | 3.72 |
Profitability
| EPS (TTM): | -0.47500 |
|---|---|
| Net Income (TTM): | $-28M |
| Gross Margin: | $-266K |
| Return on Equity: | -157.12% |
| Return on Assets: | -96.95% |
Cognition Therapeutics, Inc. Earnings Forecast
Key Cognition Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Cognition Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CGTX |
| Website: | cogrx.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 6.44 |
| Quick Ratio: | 5.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGTX Technical Analysis vs Fundamental Analysis
Sell
48
Cognition Therapeutics, Inc. (CGTX)
is a Sell
Is Cognition Therapeutics, Inc. a Buy or a Sell?
-
Cognition Therapeutics, Inc. stock is rated a SellThe current Cognition Therapeutics, Inc. [CGTX] share price is $1.54. The Score for CGTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.